» Articles » PMID: 21035512

Transport of Epidermal Growth Factor in the Stroke-injured Brain

Overview
Specialty Pharmacology
Date 2010 Nov 2
PMID 21035512
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is a neurological disorder that currently has no cure. Intrathecal delivery of growth factors, specifically recombinant human epidermal growth factor (rhEGF), stimulates endogenous neural precursor cells in the subventricular zone (SVZ) and promotes tissue regeneration in animal models of stroke. In this model, rhEGF is delivered with an invasive minipump/catheter system, which causes trauma to the brain. A less invasive strategy is to deliver rhEGF from the brain cortex; however, this requires the protein to diffuse through the brain, from the site of injection to the SVZ. Although this method of delivery has great potential, diffusion is limited by rapid removal from the extracellular space and hence for successful translation into the clinic strategies are needed to increase the diffusion distance. Using integrative optical imaging we investigate diffusion of rhEGF vs. poly(ethylene glycol)-modified rhEGF (PEG-rhEGF) in brain slices of both uninjured and stroke-injured animals. For the first time, we quantitatively show that PEG modification reduces the rate of growth factor elimination by over an order of magnitude. For rhEGF this corresponds to a two to threefold increase in predicted brain penetration distance, which we confirm with in vivo data.

Citing Articles

ERBB1 alleviates secondary brain injury induced by experimental intracerebral hemorrhage in rats by modulating neuronal death via PLC-γ/PKC pathway.

Li B, Wu J, Cao D, Cao C, Zhang J, Li X CNS Neurosci Ther. 2024; 30(3):e14679.

PMID: 38528842 PMC: 10964039. DOI: 10.1111/cns.14679.


Injectables and Depots to Prolong Drug Action of Proteins and Peptides.

Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw P, Williams G Pharmaceutics. 2020; 12(10).

PMID: 33096803 PMC: 7589296. DOI: 10.3390/pharmaceutics12100999.


Using biomaterials to modulate chemotactic signaling for central nervous system repair.

Hickey K, Stabenfeldt S Biomed Mater. 2018; 13(4):044106.

PMID: 29411713 PMC: 5991092. DOI: 10.1088/1748-605X/aaad82.


Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging.

Wolak D, Pizzo M, Thorne R J Control Release. 2014; 197:78-86.

PMID: 25449807 PMC: 4272890. DOI: 10.1016/j.jconrel.2014.10.034.


Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis.

Mouhieddine T, Itani M, Nokkari A, Ren C, Daoud G, Zeidan A Curr Neurol Neurosci Rep. 2014; 15(1):505.

PMID: 25394858 DOI: 10.1007/s11910-014-0505-1.